- call +1-201-465-4211
- email sales@mrinsights.biz
Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
Scope of the Report:
This report focuses on the Erectile Dysfunction Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
North America held the largest share of the global erectile dysfunction drugs market in 2017. The U.S. is the largest pharmaceutical market in the world, and accounts for about 94% of the market in North America. The erectile dysfunction drugs market in the U.S. is driven by the availability of recognized branded formulations such as Viagra (sildenafil citrate), Cialis (tadalafil), and Levitra/Staxyn (vardenafil). However, the looming patent expiries of these branded drugs in the near future are expected to slightly alter this scenario by the end of the forecast period.
The worldwide market for Erectile Dysfunction Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Apricus Biosciences Inc.
Cristalia Produtos Quimicos Farmaceuticos Ltd.
Bayer AG
Dong-A Pharmaceutical Co. Ltd.
Meda Pharmaceuticals, Inc.
Eli Lilly and Company
Pfizer, Inc.
S.K. Chemicals Co. Ltd.
Vivus, Inc.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Viagra (sildenafil citrate)
Cialis (tadalafil)
Levitra/Staxyn (vardenafil)
Stendra/Spedra (avanafil)
Zydena (udenafil)
Vitaros (Alprostadil Cream)
Others
Market Segment by Applications, can be divided into
Hospital Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
E-Commerce
There are 15 Chapters to deeply display the global Erectile Dysfunction Drugs market.
Chapter 1, to describe Erectile Dysfunction Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Erectile Dysfunction Drugs, with sales, revenue, and price of Erectile Dysfunction Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Erectile Dysfunction Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Erectile Dysfunction Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Erectile Dysfunction Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Erectile Dysfunction Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Viagra (sildenafil citrate)
1.2.2 Cialis (tadalafil)
1.2.3 Levitra/Staxyn (vardenafil)
1.2.4 Stendra/Spedra (avanafil)
1.2.5 Zydena (udenafil)
1.2.6 Vitaros (Alprostadil Cream)
1.2.7 Others
1.3 Market Analysis by Applications
1.3.1 Hospital Pharmacies
1.3.2 Private Clinics
1.3.3 Drug Stores
1.3.4 Retail Pharmacies
1.3.5 E-Commerce
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Apricus Biosciences Inc.
2.1.1 Business Overview
2.1.2 Erectile Dysfunction Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Apricus Biosciences Inc. Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Cristalia Produtos Quimicos Farmaceuticos Ltd.
2.2.1 Business Overview
2.2.2 Erectile Dysfunction Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Cristalia Produtos Quimicos Farmaceuticos Ltd. Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bayer AG
2.3.1 Business Overview
2.3.2 Erectile Dysfunction Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bayer AG Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Dong-A Pharmaceutical Co. Ltd.
2.4.1 Business Overview
2.4.2 Erectile Dysfunction Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Dong-A Pharmaceutical Co. Ltd. Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Meda Pharmaceuticals, Inc.
2.5.1 Business Overview
2.5.2 Erectile Dysfunction Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Meda Pharmaceuticals, Inc. Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Eli Lilly and Company
2.6.1 Business Overview
2.6.2 Erectile Dysfunction Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Eli Lilly and Company Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer, Inc.
2.7.1 Business Overview
2.7.2 Erectile Dysfunction Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer, Inc. Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 S.K. Chemicals Co. Ltd.
2.8.1 Business Overview
2.8.2 Erectile Dysfunction Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 S.K. Chemicals Co. Ltd. Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Vivus, Inc.
2.9.1 Business Overview
2.9.2 Erectile Dysfunction Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Vivus, Inc. Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Erectile Dysfunction Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Erectile Dysfunction Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Erectile Dysfunction Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Erectile Dysfunction Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Erectile Dysfunction Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Erectile Dysfunction Drugs Market Analysis by Regions
4.1 Global Erectile Dysfunction Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Erectile Dysfunction Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Erectile Dysfunction Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Erectile Dysfunction Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Erectile Dysfunction Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Erectile Dysfunction Drugs Sales and Growth Rate (2013-2018)
4.5 South America Erectile Dysfunction Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Erectile Dysfunction Drugs Sales and Growth Rate (2013-2018)
5 North America Erectile Dysfunction Drugs by Countries
5.1 North America Erectile Dysfunction Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Erectile Dysfunction Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Erectile Dysfunction Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Erectile Dysfunction Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Erectile Dysfunction Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Erectile Dysfunction Drugs Sales and Growth Rate (2013-2018)
6 Europe Erectile Dysfunction Drugs by Countries
6.1 Europe Erectile Dysfunction Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Erectile Dysfunction Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Erectile Dysfunction Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Erectile Dysfunction Drugs Sales and Growth Rate (2013-2018)
6.3 UK Erectile Dysfunction Drugs Sales and Growth Rate (2013-2018)
6.4 France Erectile Dysfunction Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Erectile Dysfunction Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Erectile Dysfunction Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Erectile Dysfunction Drugs by Countries
7.1 Asia-Pacific Erectile Dysfunction Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Erectile Dysfunction Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Erectile Dysfunction Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Erectile Dysfunction Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Erectile Dysfunction Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Erectile Dysfunction Drugs Sales and Growth Rate (2013-2018)
7.5 India Erectile Dysfunction Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Erectile Dysfunction Drugs Sales and Growth Rate (2013-2018)
8 South America Erectile Dysfunction Drugs by Countries
8.1 South America Erectile Dysfunction Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Erectile Dysfunction Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Erectile Dysfunction Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Erectile Dysfunction Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Erectile Dysfunction Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Erectile Dysfunction Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Erectile Dysfunction Drugs by Countries
9.1 Middle East and Africa Erectile Dysfunction Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Erectile Dysfunction Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Erectile Dysfunction Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Erectile Dysfunction Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Erectile Dysfunction Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Erectile Dysfunction Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Erectile Dysfunction Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Erectile Dysfunction Drugs Sales and Growth Rate (2013-2018)
10 Global Erectile Dysfunction Drugs Market Segment by Type
10.1 Global Erectile Dysfunction Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Erectile Dysfunction Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Erectile Dysfunction Drugs Revenue and Market Share by Type (2013-2018)
10.2 Viagra (sildenafil citrate) Sales Growth and Price
10.2.1 Global Viagra (sildenafil citrate) Sales Growth (2013-2018)
10.2.2 Global Viagra (sildenafil citrate) Price (2013-2018)
10.3 Cialis (tadalafil) Sales Growth and Price
10.3.1 Global Cialis (tadalafil) Sales Growth (2013-2018)
10.3.2 Global Cialis (tadalafil) Price (2013-2018)
10.4 Levitra/Staxyn (vardenafil) Sales Growth and Price
10.4.1 Global Levitra/Staxyn (vardenafil) Sales Growth (2013-2018)
10.4.2 Global Levitra/Staxyn (vardenafil) Price (2013-2018)
10.5 Stendra/Spedra (avanafil) Sales Growth and Price
10.5.1 Global Stendra/Spedra (avanafil) Sales Growth (2013-2018)
10.5.2 Global Stendra/Spedra (avanafil) Price (2013-2018)
10.6 Zydena (udenafil) Sales Growth and Price
10.6.1 Global Zydena (udenafil) Sales Growth (2013-2018)
10.6.2 Global Zydena (udenafil) Price (2013-2018)
10.7 Vitaros (Alprostadil Cream) Sales Growth and Price
10.7.1 Global Vitaros (Alprostadil Cream) Sales Growth (2013-2018)
10.7.2 Global Vitaros (Alprostadil Cream) Price (2013-2018)
10.8 Others Sales Growth and Price
10.8.1 Global Others Sales Growth (2013-2018)
10.8.2 Global Others Price (2013-2018)
11 Global Erectile Dysfunction Drugs Market Segment by Application
11.1 Global Erectile Dysfunction Drugs Sales Market Share by Application (2013-2018)
11.2 Hospital Pharmacies Sales Growth (2013-2018)
11.3 Private Clinics Sales Growth (2013-2018)
11.4 Drug Stores Sales Growth (2013-2018)
11.5 Retail Pharmacies Sales Growth (2013-2018)
11.6 E-Commerce Sales Growth (2013-2018)
12 Erectile Dysfunction Drugs Market Forecast (2018-2023)
12.1 Global Erectile Dysfunction Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Erectile Dysfunction Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Erectile Dysfunction Drugs Market Forecast (2018-2023)
12.2.2 Europe Erectile Dysfunction Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Erectile Dysfunction Drugs Market Forecast (2018-2023)
12.2.4 South America Erectile Dysfunction Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Erectile Dysfunction Drugs Market Forecast (2018-2023)
12.3 Erectile Dysfunction Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Erectile Dysfunction Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Erectile Dysfunction Drugs Market Share Forecast by Type (2018-2023)
12.4 Erectile Dysfunction Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Erectile Dysfunction Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Erectile Dysfunction Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Erectile Dysfunction Drugs Picture
Table Product Specifications of Erectile Dysfunction Drugs
Figure Global Sales Market Share of Erectile Dysfunction Drugs by Types
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
